Back to PRICE T ROWE ASSOCIATES INC /MD/ PRICE T ROWE ASSOCIATES INC /MD/

GLUEGLUE
Showing 8 of 15 quarters

Position history for PRICE T ROWE ASSOCIATES INC /MD/PRICE T ROWE ASSOCIATES INC /MD/'s holdings in MONTE ROSA THERAPEUTICS INC

PRICE T ROWE ASSOCIATES INC /MD/ holds 8.9M shares of GLUE (MONTE ROSA THERAPEUTICS INC), worth $214,442 as of 2026-Q2. The position was increased (+31.9% shares). GLUE represents 0.0% of PRICE T ROWE ASSOCIATES INC /MD/'s portfolio.

Current Value

$214,442

Current Shares

8.9M

Total Value Change

-$34.8M

Total Shares Change

+2.3M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
8.9M
+31.9%
$214,4420.0%$24.20
29
2026-Q1
Increased
6.7M
+31.3%
$110.5M0.0%$17.96
38
2025-Q4
Increased
5.1M
+10.4%
$80.3M0.0%$15.97
33
2025-Q3
Decreased
4.6M
-26.7%
$34.4M0.0%$7.31
0
2025-Q2
Decreased
6.3M
-4.8%
$28.5M0.0%$4.60
0
2025-Q1
Decreased
6.6M
-6.6%
$30.8M0.0%$5.10
0
2024-Q4
Increased
7.1M
+7.8%
$49.4M0.0%$7.02
32
2024-Q3
Increased
6.6M
+10.4%
$35M0.0%$5.17
32

Other major holders of GLUE: BlackRock, Inc., BAKER BROS. ADVISORS LP, STATE STREET CORP, VANGUARD CAPITAL MANAGEMENT LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used